3.1 Subject characteristics
In single-dose trial, 44 subjects met the selection criteria were received medication to obtain safety data and were included in the safety analysis set. In the continuous administration trial, 18 subjects met the selection criteria were received medication to obtain safety data and were included in the safety analysis set. Summary demographic information about the 62 subjects who completed the study was summarized in Table1. Healthy, non-smoking men or women average aged 27.4–30.9 years with a body mass index of 21.4–23.81 kg/m2 were eligible for inclusion in the single-dose trial. Healthy, non-smoking men or women average aged 29.7~30.5 years with a body mass index of 22.65-23.30 kg/m2 were eligible for inclusion in the continuous administration dose.